Tobira Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Tobira Therapeutics, Inc. reported Increase (Decrease) in Accounts Payable of $232.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2015-04-29
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2015-03-31 was $232.00K.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2014-12-31 was -$3.92M, a 445.98% decline year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2014-09-30 was $2.34M.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2014-06-30 was $471.00K, a 47.67% decline year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2014 was -$1.37M, a 201.33% decline from fiscal 2013.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2013 was $1.35M.
- Tobira Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2012 was -$117.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 142 month | Increase (Decrease) in Accounts Payable 145 month | Increase (Decrease) in Accounts Payable 148 month |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | $232.00K 10-Q · filed 2015-04-29 | -$3.69M derived: sum of 2 quarters · filed 2015-04-29 | -$1.34M derived: sum of 3 quarters · filed 2015-04-29 | -$873.00K derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$1.58M derived: sum of 2 quarters · filed 2015-02-12 | -$1.10M derived: sum of 3 quarters · filed 2015-02-12 | -$1.37M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.81M derived: sum of 2 quarters · filed 2014-11-06 | $2.55M 10-Q · filed 2014-11-06 | $3.68M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-06-30 | $471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $204.00K 10-Q · filed 2014-08-11 | $1.34M derived: sum of 3 quarters · filed 2015-04-29 | $172.00K derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-03-31 | -$267.00K 10-Q · filed 2015-04-29 | $866.00K derived: sum of 2 quarters · filed 2015-04-29 | -$299.00K derived: sum of 3 quarters · filed 2015-04-29 | $601.00K derived: sum of 4 quarters · filed 2015-04-29 | $1.29M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$32.00K derived: sum of 2 quarters · filed 2015-02-12 | $868.00K derived: sum of 3 quarters · filed 2015-02-12 | $1.35M 10-K · filed 2015-02-12 | $1.56M 10-K · filed 2014-03-12 | ||
| 2013-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$265.00K derived: sum of 2 quarters · filed 2014-11-06 | $221.00K 10-Q · filed 2014-11-06 | $220.00K derived: sum of 4 quarters · filed 2014-11-06 | $424.00K 10-Q · filed 2013-11-08 | ||
| 2013-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.39M 10-Q · filed 2014-08-11 | $1.39M derived: sum of 3 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $486.00K 10-Q · filed 2014-05-13 | $485.00K derived: sum of 2 quarters · filed 2014-05-13 | |||||
| 2012-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$117.00K 10-K · filed 2014-03-12 | |||||
| 2012-09-30 | -$116.00K 10-Q · filed 2013-11-08 |